Development of cancer in patients with primary immunodeficiencies

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1263-1269

  Salavoura, Katerina ^a   Kolialexi, Aggeliki ^a   Tsangaris, George ^b   Mavrou, Ariadni ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cancer; Primary immunodeficiencies; Review

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

AUTOIMMUNITY; CANCER RISK; DISORDERS OF DNA SYNTHESIS AND REPAIR; GENETIC DISORDER; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; INFECTION; LIFESPAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NEOPLASM; NONHODGKIN LYMPHOMA; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; VIRUS INFECTION; WISKOTT ALDRICH SYNDROME;

HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEOPLASMS; RISK FACTORS;

EID: 42549137374     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Mueller BU and Pizzo PA: Cancer in children with primary or secondary immunodeficiencies. J Pediatr 126: 1-10, 1996.
2. Canioni D, Jabado N, MacIntyre E et al: Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology 38: 146-159, 2001.
3. Filipovich AH, Mathur A, Kamat D et al: Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 52: 5465-5467, 1992.
4. Frizzera G, Rosai J, Dehner LP et al: Lymphoreticular disorders in primary immunodeficiencies: new findings based on an upto-date histologic classification of 35 cases. Cancer 15: 692-699, 1980.
5. Rodriguez-Abreu D, Bordoni A and Zucca E: Epidemiology of hematological malignancies. Ann Oncol 18: 3-8, 2007
6. Aghamohammadi A, Parvaneh N, Tirgari F et al: Lymphoma of mucosal-associated lymphoid tissue in common variable immunodeficiency. Pediatr Hematol Oncol 24: 337-342, 2007.
7. Wheat WH, Cool CD, Morimoto Y et al: Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 15: 479-484, 2005.
8. Cheng TY, Lin JT, Chen LT et al: Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 24: 3483-3489, 2005.
9. Rachid R, Castigli E, Geha RS and Bonilla FA: TACI mutation in common variable immunodeficiency and IgA deficiency. Curr Allergy Asthma Rep 6: 357-362, 2006.
10. Lavilla P, Gil A, Rodriguez MC et al: X-linked agammaglobulinemia and gastric carcinoma. Cancer 72: 1528-1531, 1993.
11. Van der Meer JW, Weening RS, Schellekens PT et al: Colorectal cancer in patients with X-linked agammaglobulinemia. Lancet 341: 1439-1440, 1993.
12. Zenone T, Souquet J, Cunningham AM, Rudles C et al: Hodgin's disease associated with IgA and IgG subclass deficiency. J Inter Med 240: 99-102, 1996.
13. Gompels MM, Hodges E, Lock RJ et al: Associated Study Group. Lymphoproliferative disease in antibody deficiency: a multi-centre study. Clin Exp Immunol 134: 314-320, 2003.
14. Hayward AR, Levy J, Facchetti F et al: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158: 977-983, 1997.
15. Gruss HJ, Herrmann F, Gattei V et al: CD40/CD40 ligand interactions in normal, reactive and malignant lymphohematopoietic-tissues. Leuk Lymphoma 24: 393-422, 1997.
16. de Villartay JP: V(D)J recombination and DNA repair: lessons from human immune deficiencies and other animal models. Curr Opin Allergy Clin Immunol 2: 473-479, 2002.
17. Atluri S, Neville K, Davis M et al: Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency disease. J Pediatr Hematol Oncol 29: 166-172, 2007.
18. Husain M, Grunebaum E, Naqvi A et al: Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase. J Pediatr 151: 93-95, 2007.
19. Cohen JI: Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases. Semin Hematol 40: 116-123, 2003.
20. Rao VK and Strauss SE: Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology 11: 15-23, 2006.
21. Gronbaek K, Straten PT, Ralfkiaer E et al: Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 92: 3018-3024, 1998.
22. Bertinger C, Bohler T, Schrappe M et al: The role of CD95 (APO-1/fas) mutations in lymphoproliferative and malignant lymphatic diseases. Klin Pediatr 210: 153-158, 1998.
23. Notarangelo L and Ochs H: Wiskott Aldrich syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. Cur Opin Immunol 15: 585-591, 1998.
24. Ochs HD and Thrasher AJ: The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117: 725-738, 2006.
25. Palenzuela G, Bernard F, Gardiner Q et al: Malignant B cell non-Hodgkin's lymphoma of the larynx in children with Wiskott Aldrich syndrome. Int J Pediatr Otorhinolaryngol 67: 989-993, 2003.
26. Picard C, Mellouli F, Duprez R et al: Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr 165: 453-457, 2006.
27. Meropol NJ, Hicks D, Brooks JJ et al: Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome. Am J Hematol 40: 126-134, 1992.
28. Scattone A, Caruso G, Marzullo A et al: Neoplastic disease and deletion 22q11.2: a multicentric study and report of two cases. Pediatr Pathol Mol Med 22: 323-341, 2003.
29. Patrone PM, Chatten J and Weinberg P: Neuroblastoma and DiGeorge anomaly. Pediatr Pathol 10: 425-430, 1990.
30. Ehrlich M: The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol 109: 17-28, 2003.
31. Gennery A: Primary immunodeficiency syndromes associated with defective DNA double-strand break repair. Br Medical Bulletin 77 & 78: 71-85, 2006.
32. Thomson D, Duedal S, Kirner J et al: Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97: 813-822, 2005.
33. Umesako S, Fujisawa K, Liga S et al: ATM heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice. Breast Cancer Res 7: 164-170, 2005.
34. Kondratenko I, Paschenko O, Polyakov A et al: Nijmegen breakage syndrome. Adv Exp Med Biol 601: 61-67, 2007.
35. Mathew CG: Fanconi anaemia genes and susceptibility to cancer. Oncogene 25: 5875-5884, 2006.
36. Patel KJ: Fanconi anemia and breast cancer susceptibility. Nat Genet 39: 142-143, 2007.
37. Song H, Ramus SJ, Kjaer SK et al: Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS ONE. 7, e268, 2007.
38. Moshous D, Callebaut I, de Chasseval R, Poinsignon C, Villey I, Fischer A and de Villartay JP: The V(D)J recombination/DNA repair factor artemis belongs to the metallo-beta-lactamase family and constitutes a critical developmental checkpoint of the lymphoid system. Ann NY Acad Sci 987: 150-157, 2003.
39. Friedberg EC and Wood RD: New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability. Mol Cell 26: 162-164, 2007.
40. Eisner JM and Russell M: Cartilage hair hypoplasia and multiple basal cell carcinomas. J Am Acad Dermatol 54: 8-10, 2006.
41. Horwitz M, Li FQ, Albani D et al: Leukemia in severe congenital neutropenia: defective proteolysis suggests new pathways to malignancy and opportunities for therapy. Cancer Invest 21: 579-587, 2003.
42. Sato T, Takahashi S, Mizumoto T et al: Neutrophil elastase and cancer. Surg Oncol 15: 217-222, 2006.
43. Shimamura A: Shwachman-Diamond syndrome. Semin Hematol 43: 178-188, 2006.
44. Onal IK, Kurt M, Altundeg K et al: Peripheral T-cell lymphoma and Job's syndrome: a rare association. Med Oncol 23: 141-144, 2006.
45. Grimbacher B, Holland S and Puck J: Hyper-IgE syndromes. Immunol Rev 203: 244-250, 2005.
46. Wolach B, Ash S, Gavrieri R et al: Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report. Am J Hematol 80: 50-54, 2005.
47. Diaz G: CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunological Rev 203: 235-243, 2005.
48. García JM, Español T, Gurbindo MD, Casas CC: Update on the treatment of primary immunodeficiencies. Allergol Immunopathol 35: 184-192, 2007.
49. Chinen J, Davis J, De Ravin SS et al: Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency. Blood 110: 67-73, 2007.
50. Thrasher AJ, Gaspar HB, Baum C et al: Gene therapy: X-SCID transgene leukaemogenicity. Nature 443: 5-6, 2007.